Two recent papers shine a light on monoclonal gammopathy of undetermined significance (MGUS), a premalignant condition that is prevalent in the general population, affecting about 3% of individuals ...

The rate of MGUS among hospitalized patients over 50 was twice as high as that of the same age group in the general population. Higher rates of MGUS were prevalent among patients who had elevated ...

Please provide your email address to receive an email when new articles are posted on . According to data from a population-based study, monoclonal gammopathy of undetermined significance was ...

Patients with multiple myeloma (MM) appear to have better survival if they are found to have monoclonal gammopathy of undetermined significance (MGUS) first, the state that precedes MM and which is ...

Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to protect us from infections. However, the cells grow too much in myeloma, crowding ...

Please provide your email address to receive an email when new articles are posted on . Patients with multiple myeloma who were previously diagnosed with monoclonal gammopathy of undetermined ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...

If you have multiple myeloma, cancerous plasma cells divide and grow inside your bone marrow. Plasma cells are white blood cells that make antibodies. Antibodies are part of your immune system. They ...